FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to the method for amplification of nucleic acids of the heavy and light chain of human immunoglobulins.
EFFECT: invention makes it possible to reduce the probability of false-negative amplification, increasing the probability of successful amplification of cDNA antibodies with rarely occurring alleles of V gene segments.
1 cl, 16 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MUS MUSCULUS 5B9 HYBRID CULTIVATED ANIMAL CELLS- A PRODUCER OF MOUSE MONOCLONAL ANTIBODY 5B9, MONOCLONAL MOUSE ANTIBODY 5B9 AND RECOMBINANT CHIMERIC (MOUSE-HUMAN) ANTIBODY XI5B9, NEUTRALIZING RICIN RICINUS COMMUNIS | 2022 |
|
RU2802436C1 |
| METHOD OF PRODUCING DIMERIC FORM OF MUTANT IGA2M1-ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2023 |
|
RU2822889C1 |
| ANIMALS OTHER THAN HUMANS WITH CONSTRUCTED LOCUS OF LIGHT LAMBDA CHAIN OF IMMUNOGLOBULIN | 2017 |
|
RU2757665C2 |
| 1E10 MONOCLONAL MOUSE ANTIBODY 1E10 AND RECOMBINANT CHIMERIC (MOUSE-HUMAN) ANTIBODY XI1E10, NEUTRALIZING BACILLUS ANTHRACIS LETHAL TOXIN, AND A STRAIN OF HYBRID CULTURED ABIMAL CELLS -MUS MUSCULUS 1E10 | 2020 |
|
RU2745116C1 |
| METHOD OF PRODUCING DIMERIC FORM OF IMMUNOGLOBULIN IGA1-ISOTYPE IN MAMMALIAN CELLS | 2023 |
|
RU2822890C1 |
| HUMANISED LIGHT CHAIN MICE | 2012 |
|
RU2664181C2 |
| METHOD FOR PRODUCING RECOMBINANT IGA2m1 ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2022 |
|
RU2801178C1 |
| NON-HUMAN ANIMALS WITH CONSTRUCTED LIGHT CHAIN OF LAMBDA IMMUNOGLOBULIN, AND THEIR USE | 2018 |
|
RU2778410C2 |
| MICE EXPRESSING AN IMMUNOGLOBULIN HYBRID LIGHT CHAIN | 2011 |
|
RU2601297C2 |
| MICE, EXPRESSING LIGHT CHAIN WITH VARIABLE REGION OF ALPHA HUMAN AND CONSTANT AREA OF MOUSE | 2011 |
|
RU2590594C2 |
